PANEL DISCUSSION: Evaluate the Current Challenges, Approaches and Opportunities in Treating Glioblastoma

Time: 1:50 pm
day: Day One


  • A year on from the inaugural GBM Drug Development meeting: What have we learnt?
  • How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?
  • The impact of COVID-19 and its repercussions on existing clinical trials